1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global rcolepsy Market - By Type
1.3.2 Global rcolepsy Market - By Product
1.3.3 Global rcolepsy Market - By Distribution Channel
1.3.4 Global rcolepsy Market - By Geography

2. GLOBAL RCOLEPSY MARKET - KEY TAKEAWAYS

3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research

4. GLOBAL RCOLEPSY MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ALYSIS
4.2.1 North America - PEST Alysis
4.2.2 Europe- PEST Alysis
4.2.3 Asia Pacific- PEST Alysis
4.2.4 Middle East & Africa- PEST Alysis
4.2.5 South and Central America - PEST Alysis

5. GLOBAL RCOLEPSY MARKET - KEY MARKET DYMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Sleep Related Neurological Disorders
5.1.2 Emerging Local Pharmaceutical and Biopharmaceutical Companies
5.1.3 Increasing Awareness Regarding Neurological Disorders
5.2 KEY MARKET RESTRAINTS
5.2.1 Side Effects and Risks Associated with rcolepsy Medications
5.2.2 Delayed Diagnosis or Misdiagnosis of rcolepsy
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Robust Pipeline Drugs for rcolepsy
5.4 FUTURE TRENDS
5.4.1 New Treatments for rcolepsy
5.5 IMPACT ALYSIS

6. RCOLEPSY MARKET - GLOBAL ALYSIS
6.1 GLOBAL RCOLEPSY MARKET REVENUE FORECASTS AND ALYSIS
6.2 GLOBAL RCOLEPSY MARKET, BY GEOGRAPHY - FORECASTS AND ALYSIS
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Jazz Pharmaceuticals plc
6.3.2 Teva Pharmaceutical Industries Ltd.
6.4 BRAND ALAYSIS
6.4.1 Marketed Drugs:
6.4.2 Provigil
6.4.2.1 Overview:
6.4.2.2 Drug Description:
6.4.2.3 Advantages & Disadvantages:
6.4.3 Xyrem
6.4.3.1 Overview:
6.4.3.2 Drug Description:
6.4.3.3 Advantages & Disadvantages:
6.4.4 Nuvigil
6.4.4.1 Overview:
6.4.4.2 Drug Description:
6.4.4.3 Advantages & Disadvantages:
6.5 PIPELINE ALYSIS

7. RCOLEPSY MARKET ALYSIS AND FORECASTS TO 2027 - TYPE
7.1 OVERVIEW
7.2 TYPE MARKET REVENUE AND FORECASTS ALYSIS (US$ MN)
7.3 RCOLEPSY WITH CATAPLEXY MARKET
7.3.1 Overview
7.3.2 rcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.4 RCOLEPSY WITHOUT CATAPLEXY MARKET
7.4.1 Overview
7.4.2 rcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.5 SECONDARY RCOLEPSY MARKET
7.5.1 Overview
7.5.2 Secondary rcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

8. RCOLEPSY MARKET ALYSIS AND FORECASTS TO 2027 - PRODUCT
8.1 OVERVIEW
8.2 PRODUCT MARKET REVENUE AND FORECASTS ALYSIS (US$ MN)
8.3 CENTRAL NERVOUS SYSTEM STIMULANTS MARKET
8.3.1 Overview
8.3.2 Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)
8.4 SODIUM OXYBATE MARKET
8.4.1 Overview
8.4.2 Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)
8.5 ANTIDEPRESSANTS MARKET
8.5.1 Overview
8.5.2 Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)

9. RCOLEPSY MARKET ALYSIS AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DISTRIBUTION CHANNEL MARKET REVENUE AND FORECASTS ALYSIS (US$ MN)
9.3 HOSPITAL PHARMACIES MARKET
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.4 RETAIL PHARMACIES MARKET
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10. RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ALYSIS
10.1 NORTH AMERICA RCOLEPSY MARKET
10.1.1 Overview
10.1.2 North America rcolepsy Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.3 North America rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.5 North America rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.6 North America rcolepsy Market Revenue And Forecasts to 2027, By Country (%)
10.1.7 US rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.2 US rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3 US rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.9 Cada rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Cada rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Cada rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.2 Cada rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3 Cada rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.11 Mexico rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1 Mexico rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.2 Mexico rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.12.3 Mexico rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2 EUROPE RCOLEPSY MARKET
10.2.1 Overview
10.2.2 Europe rcolepsy market revenue Overview, by Country (2017) (us$ mn)
10.2.3 Europe rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.4 Europe rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.5 Europe rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.6 Europe rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.7 Europe rcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.2.8 Germany rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9 Germany rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 Germany rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.9.2 Germany rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.9.3 Germany rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.10 UK rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11 UK rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 UK rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.11.2 UK rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.11.3 UK rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.12 France rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13 France rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13.1 France rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.13.2 France rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.13.3 France rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.14 Italy rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15 Italy rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15.1 Italy rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.15.2 Italy rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.15.3 Italy rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.16 Spain rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17 Spain rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17.1 Spain rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.17.2 Spain rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.17.3 Spain rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3 ASIA PACIFIC RCOLEPSY MARKET
10.3.1 Overview
10.3.2 Asia Pacific rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.4 Asia Pacific rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.5 Asia Pacific rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.6 Asia Pacific rcolepsy Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 Chi rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8 Chi rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 Chi rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.8.2 Chi rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.8.3 Chi rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.9 Japan rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10 Japan rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1 Japan rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.10.2 Japan rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.10.3 Japan rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.11 India rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12 India rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12.1 India rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.12.2 India rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.12.3 India rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.13 Australia rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14 Australia rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14.1 Australia rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.14.2 Australia rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.14.3 Australia rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.15 South Korea rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16 South Korea rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16.1 South Korea rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.16.2 South Korea rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.16.3 South Korea rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4 MIDDLE EAST & AFRICA RCOLEPSY MARKET
10.4.1 Middle East & Africa rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2 Middle East & Africa rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.3 Middle East & Africa rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.4 Middle East & Africa rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.5 Middle East & Africa rcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.4.6 UAE rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7 UAE rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 UAE rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.7.2 UAE rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.7.3 UAE rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.8 Saudi Arabia rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9 Saudi Arabia rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 Saudi Arabia rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.9.2 Saudi Arabia rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.9.3 Saudi Arabia rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.10 South Africa rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11 South Africa rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11.1 South Africa rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.11.2 South Africa rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.11.3 South Africa rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5 SOUTH AND CENTRAL AMERICA RCOLEPSY MARKET
10.5.1 Overview
10.5.2 South and Central America rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South & Central America rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.4 South & Central America rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.5 South & Central America rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.6 South and Central America rcolepsy Market Share by Country, 2017 and 2027 (%)
10.5.7 Brazil rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8 Brazil rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.8.2 Brazil rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.8.3 Brazil rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.9 Argenti rcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10 Argenti rcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10.1 Argenti rcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.10.2 Argenti rcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.10.3 Argenti rcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11. RCOLEPSY MARKET - INDUSTRY LANDSCAPE
11.1 OVERVIEW
11.2 COMPARATIVE COMPANY ALYSIS
11.3 GROWTH STRATEGIES IN THE RCOLEPSY MARKET, 2015-2018
11.4 ORGANIC GROWTH STRATEGIES
11.4.1 Overview
11.4.2 Expansions
11.4.3 Product Launches
11.4.4 Other Organic Growth Strategies
11.5 INORGANIC GROWTH STRATEGIES
11.5.1 Overview
11.5.2 Agreements
11.5.3 Acquisitions
11.5.4 Other Inorganic Growth Strategies

12. RCOLEPSY MARKET -KEY COMPANY PROFILES
12.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Fincial Overview
12.1.4 Product Portfolio
12.1.5 Swot Alysis
12.1.6 Key Developments
12.2 JAZZ PHARMACEUTICALS PLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Fincial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Alysis
12.2.6 Key Developments
12.3 ARE PHARMACEUTICALS, INC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Fincial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Alysis
12.3.6 Key Developments
12.4 GRAYMARK HEALTHCARE, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Fincial Information
12.4.4 Product Portfolio
12.4.5 SWOT Alysis
12.4.6 Key Developments
12.5 NOVARTIS AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Fincial Information
12.5.4 Product Portfolio
12.5.5 SWOT Alysis
12.5.6 Key Developments
12.6 TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Fincial Information
12.6.4 Product Pipeline
12.6.5 SWOT Alysis
12.6.6 Key Developments
12.7 MYLAN N.V.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Fincial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Alysis
12.7.6 Key Developments
12.8 BIOPROJET
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Fincial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Alysis
12.8.6 Key Developments
12.9 SHIONOGI & CO., LTD.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Fincial Overview
12.9.4 Product Portfolio
12.9.5 Product Pipeline
12.9.6 SWOT Alysis
12.9.7 Key Developments
12.10 LIGAND PHARMACEUTICALS, INC.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Fincial Overview
12.10.4 Product Portfolio
12.10.5 Product Pipeline
12.10.6 SWOT Alysis
12.10.7 Key Developments

13. APPENDIX
13.1 ABOUT THE INSIGHT PARTNERS
13.2 GLOSSARY OF TERMS

LIST OF TABLES
TABLE 1. NORTH AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 2. NORTH AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 3. NORTH AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 4. US RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. US RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. US RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 7. CADA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 8. CADA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 9. CADA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 10. MEXICO RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 11. MEXICO RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 12. MEXICO RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 13. EUROPE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 14. EUROPE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 15. EUROPE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 16. GERMANY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. GERMANY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 18. GERMANY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 19. UK RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. UK RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 21. UK RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 22. FRANCE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 23. FRANCE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 24. FRANCE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 25. ITALY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 26. ITALY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 27. ITALY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 28. SPAIN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 29. SPAIN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. SPAIN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 31. ASIA PACIFIC RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. ASIA PACIFIC RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 33. ASIA PACIFIC RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 34. CHI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 35. CHI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 36. CHI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 37. JAPAN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 38. JAPAN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 39. JAPAN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 40. INDIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 41. INDIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 42. INDIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 43. AUSTRALIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 44. AUSTRALIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 45. AUSTRALIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 46. SOUTH KOREA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 47. SOUTH KOREA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 48. SOUTH KOREA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 49. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 50. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 51. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 52. UAE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 53. UAE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 54. UAE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 55. SAUDI ARABIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 56. SAUDI ARABIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 57. SAUDI ARABIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 58. SOUTH AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 59. SOUTH AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 60. SOUTH AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 61. SOUTH & CENTRAL AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 62. SOUTH & CENTRAL AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 63. SOUTH & CENTRAL AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 64. BRAZIL RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 65. BRAZIL RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 66. BRAZIL RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 67. ARGENTI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 68. ARGENTI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 69. ARGENTI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 70. RECENT EXPANSIONS IN THE RCOLEPSY MARKET
TABLE 71. RECENT PRODUCT LAUNCHES IN THE RCOLEPSY MARKET
TABLE 72. OTHER ORGANIC GROWTH STRATEGIES IN THE RCOLEPSY MARKET
TABLE 73. RECENT AGREEMENTS IN THE RCOLEPSY MARKET
TABLE 74. RECENT ACQUISITIONS IN THE RCOLEPSY MARKET
TABLE 75. RECENT OTHER INORGANIC GROWTH STRATEGIES IN THE RCOLEPSY MARKET
TABLE 76. GLOSSARY OF TERMS, RCOLEPSY MARKET

LIST OF FIGURES
FIGURE 1. RCOLEPSY MARKET SEGMENTATION
FIGURE 2. BIOREACTORS SEGMENTATION, BY REGION
FIGURE 3. ASIA PACIFIC RCOLEPSY MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 4. GLOBAL RCOLEPSY MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 5. GLOBAL RCOLEPSY MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 6. GLOBAL RCOLEPSY MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2018
FIGURE 7. NORTH AMERICA PEST ALYSIS
FIGURE 8. EUROPE PEST ALYSIS
FIGURE 9. ASIA PACIFIC PEST ALYSIS
FIGURE 10. MIDDLE EAST & AFRICA PEST ALYSIS
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ALYSIS
FIGURE 12. RCOLEPSY MARKET IMPACT ALYSIS OF DRIVER AND RESTRAINTS
FIGURE 13. GLOBAL RCOLEPSY MARKET - REVENUE FORECASTS AND ALYSIS -2018- 2027
FIGURE 14. GLOBAL RCOLEPSY MARKET - BY GEOGRAPHY FORECASTS AND ALYSIS - 2018- 2027
FIGURE 15. TYPE MARKET ALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 16. RCOLEPSY WITH CATAPLEXY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. RCOLEPSY WITHOUT CATAPLEXY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. SECONDARY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. PRODUCT MARKET ALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 20. CENTRAL NERVOUS SYSTEM STIMULANTS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. SODIUM OXYBATE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. ANTIDEPRESSANTS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. DISTRIBUTION CHANNEL MARKET ALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 24. HOSPITAL PHARMACIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. RETAIL PHARMACIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. NORTH AMERICA RCOLEPSY MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 27. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. NORTH AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 29. US RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. CADA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. MEXICO RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. EUROPE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. EUROPE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 34. GERMANY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. UK RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. FRANCE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. ITALY RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. SPAIN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. ASIA PACIFIC RCOLEPSY MARKET REVENUE OVERVIEW, BY COUNTRY (2018) (US $ MN)
FIGURE 40. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. ASIA PACIFIC RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 42. CHI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. JAPAN RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. INDIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 45. AUSTRALIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 46. SOUTH KOREA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 48. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. MIDDLE EAST & AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 50. UAE RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 51. SAUDI ARABIA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 52. SOUTH AFRICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 53. SOUTH AND CENTRAL AMERICA RCOLEPSY MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 54. SOUTH AND CENTRAL AMERICA RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 55. SOUTH AND CENTRAL AMERICA RCOLEPSY MARKET SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 56. BRAZIL RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 57. ARGENTI RCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 58. COMPARATIVE COMPANY ALYSIS
FIGURE 59. GROWTH STRATEGIES IN THE RCOLEPSY MARKET, 2015-2018
FIGURE 60. ORGANIC GROWTH STRATEGIES IN THE RCOLEPSY MARKET, 2015-2018
FIGURE 61. INORGANIC GROWTH STRATEGIES IN THE BIOREACTOR MARKET, 2015-2018

The List of Companies
1. Bioprojet
2. Teva Pharmaceutical Industries Ltd.
3. Jazz Pharmaceuticals, Inc.
4. Graymark Healthcare, Inc.
5. Arena Pharmaceuticals, Inc.
6. Shire (Acquired by Takeda)
7. Ligand Pharmaceuticals, Inc.
8. Novartis AG
9. Mylan N.V.
10. Shionogi Inc.